Background To date, only dexamethasone and tocilizumab have been shown to reduce
mortality in patients with COVID-19. Baricitinib is a Janus kinase 1/2 inhibitor with known anti-…

BACKGROUND: Dexamethasone, a synthetic glucocorticoid, has anti-inflammatory and
immunosuppressive properties. There is a hyperinflammatory response involved in the clinical …

To date, there have only been a few reports of reinfections in COVID-19 patients. The possibility
of being reinfected with COVID-19 is poorly understood. In this case report, we describe …

A 52-year-old man with a recent diagnosis of COVID-19 3 weeks ago presented to the hospital
with multiple episodes of haemoptysis, intermittent cough and shortness of breath. There …

To date, there have been reports of neurologic manifestations in Covid-19 patients including
ischemic strokes, Guillain-Barre Syndrome and anosmia. In this case report, we describe a …

Background To date, only dexamethasone has been shown to reduce mortality in coronavirus
disease-19 (COVID-19) patients. Tocilizumab has been recently added to the treatment …

Importance Diagnostic errors contribute to patient harm, though few data exist to describe
their prevalence or underlying causes among medical inpatients. Objective To determine the …

COVID-19 and granulomatosis with polyangiitis share many clinical and radiological features,
making it challenging for clinicians to distinguish between the two. In this case report, we …

Background Since the beginning of COVID-19 pandemic, there has been a widespread use
of remdesivir in adults and children. There is little known information about remdesivir's role …

Background Since the pandemic began in 2020, Remdesivir has been widely used for the
treatment of coronavirus disease-2019 (COVID-19). Here, we describe a case of a patient with …